Incannex Healthcare Inc.
IXHLDrugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How IXHL's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
IHL-42X Low Dose | Phase 3 | Obstructive Sleep Apnea | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Incannex Healthcare Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Incannex Healthcare Inc.'s (IXHL) pipeline across Phase 3. Its lead program is IHL-42X Low Dose (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Incannex Healthcare Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Incannex Healthcare Inc. (IXHL) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track IXHL biotech catalysts?→
Add IXHL to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Incannex Healthcare Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.